Beyond Air Inc (XAIR) Noticias

XAIR new 52 week low

XAIR new 52 week low

XAIR 10Q expected Monday 6/24

XAI under $2

XAIR under $2

XAIR under $2

XAIR under $2

XAIR new 52 week low

XAIR new 52 week low

Beyond Air® To Participate in Three Upcoming Investor Conferences
LifeSci Partners HealthTech Symposium – September 20-21, 2022
Title: Beyond Air (XAIR) Fireside Chat
Date & Time: Wednesday, September 21, 2022, at 12:00 – 12:25pm ET
Moderator: Corey Davis, Ph.D., LifeSci Advisors, LLC
Participant: Steve Lisi, Chairman & CEO, Beyond Air
Location: Virtual
Webcast Link: Link
Ladenburg Thalmann Healthcare Conference – September 29, 2022
Title: Beyond Air (XAIR) Company Presentation
Date & Time: Thursday, September 29, 2022, at 1:30pm – 1:55pm ET
Presenter: Steve Lisi, Chairman & CEO, Beyond Air
Location: Sofitel New York City
Webcast Link: Link
Roth Inaugural Healthcare Opportunities Conference – October 6, 2022
Title: Beyond Air (XAIR) Company Presentation
Date & Time: Thursday, October 6, 2022, (Time - TBD)
Presenter: Steve Lisi, Chairman & CEO, Beyond Air
Location: The Yale Club, New York City
Webcast Link: TBD

https://stockhouse.com/news/press-releases/2022/09/16/beyond-air-xae-to-participate-in-three-upcoming-investor-conferences

GARDEN CITY, N.Y., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond Cancer, ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, today announced an update to the expectations for U.S. Food and Drug Administration (FDA) approval of LungFit® PH for the treatment of persistent pulmonary hypertension of the newborn, or PPHN. https://www.beyondair.net/news-and-events/press-releases/detail/153/beyond-air-provides-regulatory-update-for-lungfit-ph

How is nitric oxide stored in the human body?
Nitric oxide does not usually exist in its free form in the body due to its unstable nature but reacts with other molecules to form more stable products.

In the blood, nitric oxide has a very short half-life and rapidly oxidises to nitrite. It is then further oxidised with oxyhaemoglobin to produce nitrate. Nitric oxide also reacts directly with oxyhaemoglobin to produce methhaemoglobin and nitrate.
Reactions with cysteine residues in proteins lead to formation of nitrosylated products. Because of its high affinity to sulfhydryl groups (thiols), S-nitrosothiols (RSNOs) are the most common nitrosylated product in plasma.
Nitrate is the main storage form of nitric oxide. It is very stable when compared with other storage forms such as nitrites and RSNOs, which are important carriers and donor molecules of nitric

Beyond Air (XAIR) Investor Presentation - Slideshow
The following slide deck was published by Beyond Air, Inc. in conjunction with this event.

For further details see:

https://static.seekingalpha.com/uploads/sa_presentations/694/87694/original.pdf

Nitric Oxide will be the next Penicillin, the new safe antimicrobial solution to Antibiotic resistance and there are only a few companies working on it

XAIR heading for $18

I suggest you abandon your current trading strategy and try something new. Let me know if you are open to suggestions. GLTY

I just sold for loss and. It up

XAIR chart getting jiggy today. Hedge funds and institutions beginning to process this week's FDA approval news. My target is ~$20 before the end of this year. ~3x today's PPS. GLTY

https://stockcharts.com/h-sc/ui?s=XAIR&p=D&yr=0&mn=4&dy=0&id=p73405802842

Just chased on news

Huge XAIR news after hours today!!!

FDA approval achieved!

https://www.beyondair.net/news-and-events/press-releases/detail/168/beyond-airs-lungfit-ph-receives-fda-approval-to-treat

This is a very under-the-radar stock. Not many institutions are following it yet. Mostly individual investors willing to take risk. Well risk-off as of today after hours with this announcement.

My guess is this stock will start moving up overnight tonight, but big moves may take days or weeks to arrive. It will take time for institutions to process this news, and begin to make sizable investments into a now FDA-approved Med Tech stock. My target is $20 before the end of the year. Might get there much sooner though. GLTY.

Time to start paying attention again. My guess is someone knows something about the pending FDA approval and is talking... GLTY

https://datadashboard.fda.gov/ora/firmprofile.htm?FEIs=3015861988

https://stockcharts.com/h-sc/ui?s=XAIR&p=D&yr=0&mn=4&dy=0&id=p47657378776

BOOM day today !!

purchase above the days high in afterhours trading

purchase above the days high in afterhours

Should be under end year tax loss selling pressure .

Just realized that the short interest

here is way too high, almost 10%. Will probably cash out on Monday.

% of shares Held by Institutions …….. 12.84
Short Interest % of Float (03/15/20) ……. 9.6

May have found a homerun in XSPA. Check it out. I am doubling up there on Monday in the AM.

AH is looking very good here.

This seems to go up, dip a bit at midday, and then settle down by close. You may want to wait until the midday dip tomorrow. Or, you may want to buy at the open as this may not dip. Loving this and AYTU. Hopeful for PCTL and DECN.

Hey good looking.

In addition to PCTL (which is really frustrating me), I'm adding XAIR and AYTU shares daily. Hopefully you didn't touch EWLL. What a horrible investment that is. DECN looks promising, but AYTU may have grabbed the quick 5-minute blood test market. When this is over, and the market starts roaring back, we can make a ton of $$$ with NYSE and NAZ stocks. I'm hoping to use the profits from the virus stocks to buy higher quality stocks.

Good volume. Looking to see continual

movement up from this point on. Waiting for the FDA ruling.

XAIR - Good morning boston!....Looks very interesting....

https://www.otcmarkets.com/stock/XAIR/news

https://web.tmxmoney.com/pricehistory.php?qm_symbol=XAIR:US

To a Good day,

janet

iNO products may get the green light from FDA...

Looks like the possibility of FDA

fast-tracking the LungFit's application for trials on real patients is the reason for the move north. This is a great product that can be used for babies.

Trying to find out why the major

increase on Friday and this AM.

Nice move today and after hours.

Jumped into this today with a small BUY. Will follow closely.